Synapse - Dermatology

Results (47)

Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease

Research Letter

Goyal, G.; Reiner, A. S.; Bossert, D.; Sigler, A. M.; Lacouture, M. E.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; Diamond, E. L.
Blood (2025)

Fulltext@MSK | Save

Dual-targeted therapy with ruxolitinib plus duvelisib for T-cell lymphoma

Meeting Abstract

Moskowitz, A.; Ganesan, N.; Chang, T.; Davey, T.; Hancock, H.; Smith, M.; Assini, A.; Sarmasti, L.; Miller, T.; Gibaldi, A.; more...
Blood (2024)

Fulltext@MSK | Save

Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort

Meeting Abstract

Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
Blood (2024)

Fulltext@MSK | Save

Prevalence of second cancers in patients with polycythemia vera (PV): A retrospective analysis of US real-world claims data

Meeting Abstract

Pemmaraju, N.; Markova, A.; Masarova, L.; Reaven, N.; Funk, S.; Oyuela, P.; Valone, F.; Dinh, P.; Bellamy, L.; Modi, N.; more...
Blood (2023)

Fulltext@MSK | Save

Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society

Meeting Abstract

Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
Blood (2023)

Fulltext@MSK | Save

Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes

Meeting Abstract

Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
Blood (2023)

Fulltext@MSK | Save

Long-term outcomes with single-agent BRAF-inhibitor therapy in Erdheim-Chester disease

Meeting Abstract

Goyal, G.; Reiner, A.; Bossert, D.; Sigler, A.; Buthorn, J.; Lacouture, M.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; more...
Blood (2023)

Fulltext@MSK | Save

Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability

Meeting Abstract

Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
Blood (2023)

Fulltext@MSK | Save

Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial

Meeting Abstract

Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
Blood (2023)

Fulltext@MSK | Save

Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms

Meeting Abstract

Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
Blood (2023)

Fulltext@MSK | Save